IRIS
COVRE, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.399
EU - Europa 1.743
AS - Asia 455
SA - Sud America 78
AF - Africa 4
OC - Oceania 4
Totale 4.683
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.390
IE - Irlanda 465
IT - Italia 402
SG - Singapore 231
RU - Federazione Russa 206
GB - Regno Unito 187
SE - Svezia 123
FR - Francia 112
CN - Cina 110
UA - Ucraina 74
DE - Germania 73
BR - Brasile 70
VN - Vietnam 54
FI - Finlandia 33
ES - Italia 32
AT - Austria 13
HK - Hong Kong 11
IN - India 7
AZ - Azerbaigian 5
CA - Canada 5
AL - Albania 4
JO - Giordania 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
IL - Israele 3
NL - Olanda 3
PH - Filippine 3
PL - Polonia 3
AM - Armenia 2
HR - Croazia 2
IQ - Iraq 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
TR - Turchia 2
UY - Uruguay 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AR - Argentina 1
BE - Belgio 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
JP - Giappone 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TH - Thailandia 1
Totale 4.683
Salva come PNG Salva come JPEG
Città #
Dublin 463
Fairfield 407
Santa Clara 226
Ashburn 190
Woodbridge 183
Seattle 169
Cambridge 158
Houston 154
Wilmington 153
Southend 150
Singapore 82
Princeton 73
Jacksonville 72
Siena 70
New York 68
Dong Ket 50
Shanghai 45
Ann Arbor 44
Milan 42
San Mateo 38
Florence 36
San Diego 34
Rome 32
Chandler 31
Beijing 29
Málaga 29
Helsinki 28
Dearborn 25
Moscow 20
Lauterbourg 17
Fremont 15
Los Angeles 14
London 13
Nuremberg 12
Palermo 12
Hong Kong 11
Sesto Fiorentino 10
Portsmouth 9
Empoli 8
Vienna 8
Düsseldorf 7
Frankfurt am Main 7
Cascina 6
Guangzhou 6
Montevarchi 6
Orbetello 6
Piscataway 6
Redwood City 6
Asciano 5
Labico 5
Lappeenranta 5
Padova 5
San Francisco 5
San Giovanni Valdarno 5
São Paulo 5
Toronto 5
Trieste 5
Amman 4
Baku 4
Boardman 4
Catania 4
Hefei 4
Newark 4
Phoenix 4
Altamura 3
Ascoli Piceno 3
Delhi 3
Lavis 3
Norwalk 3
Novara 3
Rio de Janeiro 3
Stockholm 3
Tirana 3
Torrent 3
Abu Dhabi 2
Belford Roxo 2
Carmignano 2
Chiswick 2
Chiusdino 2
Colombo 2
Council Bluffs 2
Ferentino 2
Gallarate 2
Gavirate 2
Hounslow 2
Lima 2
Livorno 2
Montevideo 2
Nanjing 2
Naples 2
Pistoia 2
Pontedera 2
Porto Alegre 2
Salerno 2
San Nicola la Strada 2
Tashkent 2
Tel Aviv 2
Torino 2
Udine 2
Vientiane 2
Totale 3.435
Salva come PNG Salva come JPEG
Nome #
Immunomodulatory properties of DNA hypomethylating agents: Selecting the optimal epigenetic partner for cancer immunotherapy 167
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016 159
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy 143
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival 141
Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial 140
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours 137
The biology of cancer testis antigens: putative function, regulation and therapeutic potential 135
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5–7, 2017 132
“Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013 129
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma 128
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies 115
Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models 115
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications 114
Immunotherapy targeting immune check-point(s) in brain metastases 113
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012 110
Epigenetically‐Regulated Therapeutic Tumor‐Associated Antigens 107
Epigenetically-regulated Tumor-Associated Antigens in melanoma 106
Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications 106
Molecular pathways: At the crossroads of cancer epigenetics and immunotherapy 106
Whole genome methylation profiles as independent markers of survival in stage IIIc melanoma patients 101
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 99
Prognostic Potential of Integrated Whole Genome Methylation and Expression Profiling in Cutaneous Melanoma 93
Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients 92
Challenges in lung cancer therapy during the COVID-19 pandemic 92
5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man story 89
Epigenetics meets immune checkpoints 89
Epigenetic immune remodeling of mesothelioma cells: A new strategy to improve the efficacy of immunotherapy 88
null 87
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era 84
Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study 82
Cancer testis antigens in human melanoma stem cells: expression, distribution, and methylation status 77
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications 75
null 75
Cancer testis antigens and melanoma stem cells: new promises for therapeutic intervention. 74
A novel microRNA signature for the detection of melanoma by liquid biopsy 65
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 64
Immunomodulatory activity of SGI-110, a 5-aza-2 '-deoxycytidine-containing demethylating dinucleotide 64
Epigenetic mechanisms in cancer formation and progression 60
COVID and Lung Cancer 60
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches 56
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial 56
null 56
Epigenetics of melanoma: implications for immune-based therapies. Immunotherapy, 5:1103-1116, 2013 54
Immunotherapy of brain metastases: breaking a "dogma" 54
Primary analysis and 4-year follow-up of the phase III NIBIT-M2 trial in melanoma patients with brain metastases 54
A phase Ib study combining the second-generation DNA hypomethylating agent (DHA) guadecitabine (SGI-110) and ipilimumab in patients with metastatic melanoma: the NIBIT-M4 Study. 49
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology 46
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study 46
Safety and immunobiological activity of guadecitabine sequenced with ipilimumab in metastatic melanoma patients: The phase Ib NIBIT-M4 study 46
Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy 44
The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma 40
Whole genome methylation profiles and survival of melanoma patients 39
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 38
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 38
Clonal heritability of CTA expression and promoter methylation patterns in melanoma cells: Bases for epigenetic therapy? 36
Immunomodulatory activity of SGI-110, a secon generation hypometilating agent 34
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream 31
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers? 22
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome 16
Personalized Medicine for Patients with Liver, Biliary Tract, and Pancreatic Cancer 12
Totale 4.880
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 0 0 0 0 0 0 39 80
2020/2021893 26 97 59 105 94 95 41 134 33 72 32 105
2021/2022460 13 61 42 10 8 30 20 19 31 58 63 105
2022/2023547 53 38 108 51 11 100 19 32 45 32 41 17
2023/2024801 35 20 76 28 22 225 255 26 27 12 27 48
2024/20251.102 62 44 142 92 218 106 44 89 205 87 13 0
Totale 4.880